Mei Meng

发表

Major histocompatibility complexes are up‐regulated in glomerular endothelial cells via activation of c‐Jun N‐terminal kinase in 5/6 nephrectomy mice

T. Zhu, P. Vanhoutte, Jiawei Li, 2020, British journal of pharmacology.

TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration

Jing-quan Li, Jian He, Mei Meng, 2022, MedComm.

A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates

Jian He, Mei Meng, Hui Wang, 2021, Journal of clinical and translational hepatology.

Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma

Jing-quan Li, Chengrong Liu, Jian He, 2021, International journal of environmental research and public health.

Bioinformatics analyses on the immune status of renal transplant patients, a systemic research of renal transplantation

T. Zhu, Ming Xu, R. Rong, 2020, BMC Medical Genomics.

Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients

Jian He, Rui Gao, Mei Meng, 2023, Frontiers in Pharmacology.

Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies

Jian He, Jing-quan Li, Mei Meng, 2023, Frontiers in Oncology.

Identification of methylation signatures and rules for predicting the severity of SARS-CoV-2 infection with machine learning methods

Tao Huang, Kaiyan Feng, Yunpeng Cai, 2022, Frontiers in Microbiology.

Bioinformatics analyses on the immune status of renal transplant patients, a systemic research of renal transplantation

T. Zhu, Ming Xu, R. Rong, 2020, BMC Medical Genomics.

Neurogenesis-Associated Protein, a Potential Prognostic Biomarker in Anti-PD-1 Based Kidney Renal Clear Cell Carcinoma Patient Therapeutics

Mei Meng, Zi-ming Liu, Rui Gao, 2024, Pharmaceuticals.